Related Experiment Video
Updated: Jul 11, 2026
06:23
Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
Published on: May 23, 2021
Advanced multifocal tuberculous spondylitis without disk involvement and with multidrug-resistant bacilli.
Albert Neher1, Werner Kopp, Gabriele Berna
1Asklepios Professional Clinic München-Gauting, Centre for Pneumology and Thorax Surgery, Teaching Hospital of the Ludwig-Maximilians-University, Gauting, Germany. a.neher@asklepios.com
Summary
This report details a Nigerian patient with extensive, multidrug-resistant spinal tuberculosis. Successful treatment with second-line drugs avoided surgery, showing promising outcomes for this rare presentation.
Area of Science:
- Infectious Diseases
- Orthopedic Surgery
- Public Health
Background:
- Tuberculous spondylitis is a significant global health concern, often affecting the spine.
- Multidrug resistance in tuberculosis (MDR-TB) presents therapeutic challenges.
- Spinal tuberculosis without disk involvement is a less common manifestation.
Observation:
- A 23-year-old immunocompetent Nigerian patient presented with extensive, multifocal tuberculous spondylitis.
- The condition notably lacked intervertebral disk involvement.
- Sputum and L4 vertebral biopsy cultures confirmed Mycobacterium tuberculosis.
Findings:
- Drug-susceptibility testing identified multidrug resistance in the tuberculosis isolates.
- The patient received second-line anti-tuberculosis drugs.
- An excellent interim outcome was observed after 6 months of treatment.
Implications:
- This case highlights the potential for successful non-surgical management of extensive spinal tuberculosis, even with MDR-TB.
- It underscores the importance of considering tuberculosis in endemic regions presenting with spinal pathologies.
- Effective use of second-line drugs can lead to favorable outcomes, potentially reducing the need for invasive surgical procedures.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...